What Is Intravascular Lymphoma?

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system. It is also known as intravascular large B-cell lymphoma and was previously known as angiotropic lymphoma.

Intravascular lymphoma (IVL) is a very rare sub-subtype of a very common subtype of non-Hodgkin's lymphoma, extranodal diffuse large B-cell lymphoma. What happens in IVL is that cancerous lymphocytes, which are distorted in shape and size compared to healthy lymphocytes, will pile up in the associated blood vessels, causing swelling and distention.

Lymphoma Treatment Center

Insurance Accepted.
Innovative Lymphoma Treatments.
Call 415-343-6162 Today

Affecting patients at middle-age and older, as an extranodal disease Intravascular lymphoma will affect organs and this disease can affect virtually any organ in the body. Unlike most lymphomas, intravascular lymphoma does not commonly involve the lymph nodes. This also holds true for the spleen.

While the vast majority of cases of intravascular lymphoma are of B-cell lineage, rarely the disease will affect the T-cells.

Symptoms of intravascular lymphoma

Because IVL is an extranodal disease, this means that symptoms will vary, depending on the extranodal organ that is being affected. Generalized symptoms may include fatigue, but perhaps the key clinical feature of IVL is vascular obstruction and subsequent edema depending on where this is occurring and what organ(s) is affected.

The extranodal sites most frequently involved in IVL are the skin and the central nervous system, but it has also been known to affect the kidneys, lungs, and GI tract, among other organs.

Diagnosing intravascular Lymphoma

IVL is notorious for presenting itself in various and misleading ways, making diagnosis extremely difficult, especially since it is so rare that doctors are not typically looking for it. Consequently, until recently a diagnosis of intravascular lymphoma has most often been made post-mortem, after the patient has already died.

However, as pathology techniques have improved, along with imaging techniques, the diagnosis of intravascular lymphoma is being made more and more often before the patient dies and in time to offer therapeutic intervention.

Treatment and prognosis of intravascular lymphoma

Because it has traditionally been overlooked or diagnosed too late, and because of its aggressive nature, the mortality rate of intravascular lymphoma is very high. When the disease is diagnosed early, therapeutic intervention with chemotherapy has shown to be successful, even curative in some cases.

Sources

Photo: Pexels

Lymphoma Treatment Center

Insurance Accepted.
Innovative Lymphoma Treatments.
Call 415-343-6162 Today

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...